Diffusion as a Natural Contrast in MR Imaging of Peripheral Artery Disease (PAD) Tissue Changes. A Case Study of the Clinical Application of DTI for a Patient with Chronic Calf Muscles Ischemia.
Weronika MazurMałgorzata Urbańczyk-ZawadzkaRobert BanyśRafał ObuchowiczMariusz TrystułaArtur T KrzyżakPublished in: Diagnostics (Basel, Switzerland) (2021)
This paper reports a first application of diffusion tensor imaging with corrections by using the B-matrix spatial distribution method (BSD-DTI) for peripheral artery disease (PAD) detected in the changes of diffusion tensor parameters (DTPs). A 76-year-old male was diagnosed as having PAD, since he demonstrated in angiographic images of lower legs severe arterial stenosis and the presence of lateral and peripheral circulation and assigned to the double-blind RCT using mesenchymal stem cells (MSCs) or placebo for the regenerative treatment of implications of ischemic diseases. In order to indicate changes in diffusivity in calf muscles in comparison to a healthy control, a DTI methodology was developed. The main advantage of the applied protocol was decreased scanning time, which was achieved by reducing b-value and number of scans (to 1), while maintaining minimal number of diffusion gradient directions and high resolution. This was possible due to calibration via the BSD method, which reduced systematic errors and allowed quantitative analysis. In the course of PAD, diffusivities were elevated across the calf muscles in posterior compartment and lost their anisotropy. Different character was noticed for anterior compartment, in which diffusivities along and across muscles were decreased without a significant loss of anisotropy. After the intervention involving a series of injections, the improvement of DTPs and tractography was visible, but can be assigned neither to MSCs nor placebo before unblinding.
Keyphrases
- peripheral artery disease
- mesenchymal stem cells
- double blind
- umbilical cord
- high resolution
- white matter
- randomized controlled trial
- placebo controlled
- contrast enhanced
- bone marrow
- phase iii
- stem cells
- clinical trial
- cell therapy
- computed tomography
- magnetic resonance
- deep learning
- case report
- adverse drug
- magnetic resonance imaging
- convolutional neural network
- multiple sclerosis
- phase ii
- study protocol
- emergency department
- early onset
- brain injury